Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease
Wilson disease is one of the uncommon, hereditary, slowly progressing, and autosomal recessive diseases that cause motion disorders. The pathogenesis of Wilson disease is attributed to the accumulation of copper in different parts of body mainly the brain, eyes, liver, etc. due to the mutation takin...
Main Authors: | Nikita Sharma, Debashree Debasish Das, Pooja A Chawla |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Health Sciences Review |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772632023000089 |
Similar Items
-
Clinical experience on switching trientine tetrahydrochloride to trientine dihydrochloride in Wilson disease patients
by: Isabelle Mohr, et al.
Published: (2024-11-01) -
Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients
by: Eun Joo Lee, et al.
Published: (2024-07-01) -
Benefits and drawbacks of current copper chelators in Wilson disease
by: Ioan-Cristian Lupescu, et al.
Published: (2023-03-01) -
Biochemical diagnosis of Wilson’s disease: an update
by: Martínez-Morillo Eduardo, et al.
Published: (2022-04-01) -
Developing an analytical method for quantification of trientine based on modified silver nanoparticles
by: Mahsa Khodadadi, et al.
Published: (2023-11-01)